ARCHIVES

NCI-Approved Clinical Trials

This article is from The Cancer Letter archive.

Vol. 25 No. 4 | April 26, 2002

Download PDF Visit The Full Archive

Related Articles

NIH Should Review CRADA Pricing, Wyden Write to Shalala

February 5, 1993

NCI Advisors Approve New Grant Programs In Systems Genetics, Tumor Stem Cells.

November 23, 2007

Over Half of ALK-Positive NSCLC Patients Responded To Crizotinib In Colorado Study

November 26, 2010

NCI News: Varmus: “We Are Shrinking Everything” To Keep Grant Numbers Level During Cuts

November 15, 2013

Gleevec For KIT-positive Tumors Shows 92 Percent Overall Survival

July 29, 2011

Also ASCO to release abstracts to members prior to annual meeting.

January 30, 2004